FI883255L - Maenniskans papillomavirus, typ 41 dess dna och av dna:et kodade protein. - Google Patents

Maenniskans papillomavirus, typ 41 dess dna och av dna:et kodade protein. Download PDF

Info

Publication number
FI883255L
FI883255L FI883255A FI883255A FI883255L FI 883255 L FI883255 L FI 883255L FI 883255 A FI883255 A FI 883255A FI 883255 A FI883255 A FI 883255A FI 883255 L FI883255 L FI 883255L
Authority
FI
Finland
Prior art keywords
dna
type
protein encoded
human papillomavirus
papillomavirus
Prior art date
Application number
FI883255A
Other languages
English (en)
Other versions
FI100538B (fi
FI883255A0 (fi
Inventor
Margita Grimmel
Villiers Ethel-Michele De
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI883255A0 publication Critical patent/FI883255A0/fi
Publication of FI883255L publication Critical patent/FI883255L/fi
Application granted granted Critical
Publication of FI100538B publication Critical patent/FI100538B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI883255A 1987-07-11 1988-07-07 Ihmisen papilloomaviruksen, tyyppi 41, DNA, diagnostinen valmiste, dia gnostinen menetelmä ja käyttö FI100538B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873722968 DE3722968A1 (de) 1987-07-11 1987-07-11 Humaner papillomvirus typ 41, seine dna und die dafuer kodierenden proteine
DE3722968 1987-07-11

Publications (3)

Publication Number Publication Date
FI883255A0 FI883255A0 (fi) 1988-07-07
FI883255L true FI883255L (fi) 1989-01-12
FI100538B FI100538B (fi) 1997-12-31

Family

ID=6331386

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883255A FI100538B (fi) 1987-07-11 1988-07-07 Ihmisen papilloomaviruksen, tyyppi 41, DNA, diagnostinen valmiste, dia gnostinen menetelmä ja käyttö

Country Status (12)

Country Link
US (2) US5142032A (fi)
EP (1) EP0301289B1 (fi)
JP (1) JP2746380B2 (fi)
KR (1) KR970005047B1 (fi)
AT (1) ATE111158T1 (fi)
AU (1) AU617330B2 (fi)
CA (1) CA1340322C (fi)
DE (2) DE3722968A1 (fi)
DK (1) DK173259B1 (fi)
ES (1) ES2060625T3 (fi)
FI (1) FI100538B (fi)
PT (1) PT87940B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1314431B1 (en) * 1993-04-30 2008-07-16 Wellstat Biologics Corporation Purified compositions of Newcastle disease virus
DE19526386C1 (de) 1995-07-19 1997-01-02 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
JP2002541822A (ja) * 1999-04-14 2002-12-10 エム ユー エス シー ファンデーション フォー リサーチ ディベロップメント 組織特異的および病原体特異的毒性物質ならびにリボザイム
US20030059806A1 (en) * 2001-01-05 2003-03-27 Science & Technology Corporation @ Unm Probes for the detection of human papillomavirus
WO2004002416A2 (en) * 2002-06-26 2004-01-08 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3686304T2 (de) * 1985-04-04 1993-02-11 Univ Georgetown Typenspezifische papillomavirus-dns-sequenzen und peptide.
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
US4849334A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same
US4849331A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same
DE3722967A1 (de) * 1987-07-11 1989-01-19 Behringwerke Ag Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung
DE3826793A1 (de) * 1988-08-06 1990-03-08 Behringwerke Ag Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine

Also Published As

Publication number Publication date
KR890002402A (ko) 1989-04-10
AU617330B2 (en) 1991-11-28
JPS6455182A (en) 1989-03-02
EP0301289A1 (de) 1989-02-01
PT87940B (pt) 1995-03-01
FI100538B (fi) 1997-12-31
DE3722968A1 (de) 1989-01-19
US5142032A (en) 1992-08-25
US5382509A (en) 1995-01-17
DK173259B1 (da) 2000-05-29
ATE111158T1 (de) 1994-09-15
DK383488A (da) 1989-01-12
PT87940A (pt) 1989-06-30
ES2060625T3 (es) 1994-12-01
EP0301289B1 (de) 1994-09-07
DK383488D0 (da) 1988-07-08
JP2746380B2 (ja) 1998-05-06
DE3851391D1 (de) 1994-10-13
AU1887888A (en) 1989-04-20
FI883255A0 (fi) 1988-07-07
CA1340322C (en) 1999-01-19
KR970005047B1 (ko) 1997-04-11

Similar Documents

Publication Publication Date Title
NO900947D0 (no) Stablebar stol.
NO871685L (no) Stol.
EG18726A (en) 1-Nitro-2,2 diaminoethylene derivatives and their use in pest control.
FI885543L (fi) Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor.
FI884947L (fi) Tetrahydro-furo- och tieno/2,3-c/ pyridiner, deras anvaendning saosom laekemedel och foerfarande foer deras framstaellning.
IT8821719A0 (it) Piperidine pontate, loro preparazione e loro impiego come medicamenti.
DE3766533D1 (de) Kinderlaufstuhl.
FI906214A0 (fi) Renad ubikitinhydrolas, denna kodande dna sekvenser och dess anvaendning vid tillvaratagande av polypeptider.
FI885504L (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
FI901988A0 (fi) Koncentrerad, glutaraldehyd och 1,2-benzisotiazolin-3-on innehaollande, vattenhaltig loesning och dess anvaendning.
FI894629L (fi) Nya 3,4-diaminokinolin- och -pyridinfoereningar.
FI892250A7 (fi) Navkonstruktion foer en roterbar stol.
FI884991L (fi) Foerfarande foer reglering av protein glykolysation.
FI883255L (fi) Maenniskans papillomavirus, typ 41 dess dna och av dna:et kodade protein.
FI892949A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen -pg12-derivat, foerfarande foer dess framstaellning och dess anvaendning.
FI885425A7 (fi) Justerbar stol.
FI883812A7 (fi) 4'-deshydroxiepipodofyllotoxin -glukosider, syntes och anvaendning.
FI881899A0 (fi) Nya 2 ,16 -diaminoandrostaner.
ATA95689A (de) Maeh- bzw. haeckselmaschine
FI870732A0 (fi) Glycero-3(2)-fosfo-l-serinderivat och deras salter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
DK388986A (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, deres fremstillingog anvendelse
FI885025L (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
FI893366A0 (fi) 4-piperidylmetyl-2,3-dihydro-1h -isoindol- och 2,3,4,5-tetrahydro-1h-bensasepinderivat, deras framstaellning och terapeutiska anvaendning.
DE3882076D1 (de) Antischleudersteuergeraet.
DE3676256D1 (de) 3',4'-dideoxy-3'-fluorkanamycin b und dessen herstellung.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: DADE BEHRING MARBURG GMBH

FG Patent granted

Owner name: DADE BEHRING MARBURG GMBH

MA Patent expired